跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,316 条关于
“ProKidney Corp”
全部
6,316
临床试验
4,929
药物
442
机构
369
资讯
576
去年
ProKidney's Rilparencel Receives Positive FDA Feedback on Phase 3 Trial Design and Accelerated Approval Pathway
去年
ProKidney's Rilparencel Shows Promising Phase 2 Results for Diabetic Kidney Disease
去年
ProKidney Secures FDA Alignment on Accelerated Approval Pathway for Rilparencel in Chronic Kidney Disease
去年
ProKidney's Rilparencel Shows 78% Improvement in Kidney Function Decline in Phase 2 CKD Trial
去年
ProKidney Reports Positive Progress in Rilparencel Development for Advanced CKD
2年前
ProKidney Prioritizes US Market for Rilparencel, Discontinuing Ex-US Phase III CKD Trial
去年
BriaCell Therapeutics Reports Progress in Phase 3 Metastatic Breast Cancer Trial
去年
BriaCell's Bria-IMT™ Shows Promise in Metastatic Breast Cancer Phase 2 Trial
去年
Scholar Rock's Apitegromab Shows Promise in SMA, Faces Financial and Development Hurdles
去年
Anavex Life Sciences Reports Financial Results and Clinical Advancements in Neurodegenerative Disease Research
第 1 页,共 58 页
上一页
下一页